NKG2D-specific CART cells could recruit and activate endogenous antigen-specific cytotoxic CD8+ cells and CD4+ Th cells in the tumor site in a CXCR3-dependent manner, leading to improved tumor eradication [44]. The gene discussed is KLRK1; the disease is neoplasm.